← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2007Last known activity
Apr 2, 2024
Timeline
1960s
- Jun 1, 1962
Barretos Cancer Hospital— Founded
Drugs by trial phase (17 distinct, 16 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Biliary Tract Neoplasms
- Carcinoma
- Carcinoma, Squamous Cell
- Colorectal Neoplasms
- Head and Neck Neoplasms
- Hereditary Breast and Ovarian Cancer Syndrome
- Keratosis
- Keratosis, Actinic
- Kidney Diseases
- Neoplasms
- Squamous Cell Carcinoma of Head and Neck
- Triple Negative Breast Neoplasms
- Uterine Cervical Neoplasms
Recent trials (28)
- NCT06356012Lead sponsorPhase 4Apr 2, 2024
- NCT05354778CollaboratorN/AOct 31, 2022
- NCT03815903Lead sponsorPhase 3Dec 19, 2018
- NCT03416322Reponsible party - principal investigatorN/AFeb 1, 2018
- NCT03416322Lead sponsorN/AFeb 1, 2018
- NCT03233412Overall official - principal investigatorPhase 2Jan 1, 2018
- NCT03233412Lead sponsorPhase 2Jan 1, 2018
- NCT03233412Study directorPhase 2Jan 1, 2018
- NCT02978495Reponsible party - principal investigatorPhase 2May 17, 2017
- NCT02978495Lead sponsorPhase 2May 17, 2017
- NCT02608736Overall official - principal investigatorEarly Phase 1Dec 1, 2015
- NCT02608736Lead sponsorEarly Phase 1Dec 1, 2015
- NCT01930864Lead sponsorPhase 2Sep 1, 2015
- NCT03194061Overall official - principal investigatorN/AJan 1, 2015
- NCT03194061Lead sponsorN/AJan 1, 2015
Details
- Founded
- BR Jun 1, 1962
- Last known activity
- Apr 2, 2024